??? Have i missed something? I'm sick and lying about 3

New Post Public Reply Private Reply Replies (1) Message Board
Euroman-4K WinstonNC #55467
??? Have i missed something? I'm sick and lying about 3 days in bed.

Nanotech Entertainment Inc. (NTEK) Stock Research Links

NTEK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 251

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 35

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 79

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 176

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 389

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading

Top 5 Most Recently Viewed Articles

Boost Your Pup's Health with Routine and Technology

Updated Category News Views 121

Healthy Pet Routines Start with Pawfit Trackers As seasons change, it's a great opportunity to refresh not only our human routines but also those of our beloved pets. Pets thrive on consistency and routine, which contributes to their physical and mental well-being. Not only does implementing a structured schedule benefit pets, but it reinforces the bond we share with them...

Continue Reading
Revolutionizing Connectivity: World Mobile's Bold Move in Mozambique

Updated Category News Views 142

World Mobile’s Groundbreaking Initiative in Mozambique World Mobile, recognized as the sixth-largest blockchain-based connectivity company, has announced an important milestone by transitioning Mozambique's first national TV White Space (TVWS) spectrum database into the hands of local authorities, partnering with the Instituto Nacional de Comunicações de Moçambique...

Continue Reading
Ponce Bank Expands with New Coral Gables Office Offering Services

Updated Category News Views 167

Ponce Financial Group, Inc. opened its first representative office in Florida back in 2024, setting up shop at 1600 Ponce de Leon Drive in Coral Gables. This wasn't just a casual expansion; it marked a strategic move into a bustling Miami suburb packed with potential customers who either run businesses there or flock to the area during winter months. The whole idea was to...

Continue Reading
Cough Assist Devices Market Set for Expansive Growth Ahead

Updated Category News Views 150

Cough Assist Devices Market Analysis The cough assist devices market is poised for substantial growth, with projections indicating it could soar to USD 547.99 million in the upcoming years. This remarkable increase is expected to occur at a compound annual growth rate (CAGR) of 7.24% from its 2024 valuation of USD 275.99 million, as reported by a recent study from a...

Continue Reading
Transforming Futures Analysis with DOM Heatmap Integration

Updated Category News Views 189

Unveiling New Market Analysis Tools dxFeed, a frontrunner in market data solutions and index management, has partnered with ATAS to introduce a transformative approach to futures market analysis by offering historical DOM Levels, also known as Heatmap data. This innovative collaboration harnesses the power of historical order book liquidity data from major exchanges,...

Continue Reading